TCL Archive OMB Restrictions On Reprogramming Could Result In Inefficient Last Minute Spending By Institutes September 13, 1985
TCL Archive New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years October 26, 2012